Specialty
Orthopedic Surgery devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
0
510(k), De Novo and PMA
Decisions, last 36 months
0
Recruiting device trials
120
Industry sponsored
Adverse event reports
77,149
Received Nov 1, 2025 to Nov 19, 2026
Narrower views
Latest FDA decisions
The 0 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
No decisions for this specialty since 2015.
FDA decisions per month
Last 36 months, by decision date and pathway.
No decisions to chart for this view.
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
Stryker InstrumentsPublic (SYK)
NCT03072927 · 8,000 participants (planned) · Start Mar 10, 2017 · Primary completion Dec 2026
Device: MILD; Interspinous Process Decompression · For: Lumbar Spinal Stenosis
Sites: Athens, Alabama; Bay Minette, Alabama; Birmingham, Alabama · 2,450 sites in all
- Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)Pivotal-lookingRecruiting
Aesculap AGNot on our public-company list
NCT05547984 · 100 participants (planned) · Start Nov 21, 2022 · Primary completion Sep 2027
Device: Dual Mobility Cup; Standard Acetabular component · For: Coxarthrosis; Primary
Sites: Ústí nad Labem, Czechia
MSK Doctors & Associates LtdNot on our public-company list
NCT07932821 · 60 participants (planned) · Start Dec 2026 · Primary completion Jun 2028
Device: Electrical Muscle Stimulation · For: Muscular Atrophy; Muscle Weakness; Muscle Weakness or Atrophy
Sites: Sleaford, United Kingdom
- BioPoly® Partial Resurfacing Knee Implant IDEPivotal-lookingRecruiting
BioPoly LLCNot on our public-company list
NCT06915363 · 152 participants (planned) · Start Mar 17, 2025 · Primary completion Dec 2028
Device: BioPoly · For: Knee Pain Chronic; Knee Osteoarthritis; Cartilage Damage and 3 more
Sites: Redwood City, California; Fort Wayne, Indiana; Indianapolis, Indiana · 6 sites in all
- Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular AtrophyRecruiting
Alcyone Therapeutics, IncNot on our public-company list
NCT05866419 · 90 participants (planned) · Start Nov 27, 2023 · Primary completion Apr 2028
Device: ThecaFlex DRx System · For: Spinal Muscular Atrophy; Spine Deformity; Scoliosis
Sites: Phoenix, Arizona; Orange, California; Palo Alto, California · 23 sites in all
- Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.Pivotal-lookingRecruiting
Biocomposites LtdNot on our public-company list
NCT07270380 · 139 participants (planned) · Start Oct 20, 2026 · Primary completion Oct 2027
Device: genex with gentamicin (genex G) · For: Osteomyelitis
Sites: San Diego, California; Indianapolis, Indiana; Baltimore, Maryland · 4 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
77,149
Received Nov 1, 2025 to Nov 19, 2026. Includes 102 of another or unstated type.
Malfunction reports
38,564
50% of reports
Injury reports
38,402
50% of reports
Death reports
81
0.1% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 2,853 | 3,342 | 4 | 1 |
| Dec 25 | 3,647 | 3,896 | 3 | 0 |
| Jan 26 | 2,916 | 2,855 | 6 | 2 |
| Feb 26 | 3,043 | 2,818 | 2 | 0 |
| Mar 26 | 3,470 | 3,084 | 26 | 1 |
| Apr 26 | 3,607 | 3,578 | 8 | 0 |
| May 26 | 2,919 | 3,021 | 2 | 0 |
| Jun 26 | 3,259 | 3,534 | 9 | 1 |
| Jul 26 | 3,272 | 3,174 | 13 | 5 |
| Aug 26 | 3,068 | 3,195 | 2 | 32 |
| Sep 26 | 3,513 | 3,073 | 1 | 32 |
| Oct 26 | 2,997 | 2,832 | 5 | 28 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.